Figure S2 from Decreased Mitochondrial DNA Content Drives OXPHOS Dysregulation in Chromophobe Renal Cell Carcinoma

Abstract
Plasma and urine GSH levels cannot be used as a marker to distinguish RCC patients from healthy control subjects